Inhibiting P38 and Jun N-terminal kinase, as demonstrated by one report, decreases hepatocyte steatosis and apoptosis in a rat model of NAFLD [56]. Here, MAPK8 is linked to metabolic dysfunction-associated steatotic liver disease.